Quanterix Corporation (NASDAQ: QTRX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT QUANTERIX CORPORATION

Quanterix Corporation (NASDAQ: QTRX)
Listen to this Section


$3.79
+0.2550 ( +7.22% ) 464.7K

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.

Market Data


Open $3.79
Previous Close $3.53
Volume 464.7K
Market Cap $166.28M
Day Range $3.47 - $4.03
52 Week Range $2.40 - $8.77
Shares Outstanding 47.11M
Change % +7.22%
Net Change ▲ 0.2550
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2017
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 323,663.00

Date Type Amount Purchased Purchaser
2024-07-02 Sale -1182.00 Hlavinka Sarah E.
2024-07-02 Sale -985.00 DONNELLY WILLIAM P
2024-07-01 Sale -368.00 Toloue Masoud
2024-06-17 Sale -1120.00 Toloue Masoud
2024-06-03 Sale -1054.00 Toloue Masoud

SEC Filings


Form Type Description Pages Date
8-k 8K-related 25 Nov 10, 2025
10-q Quarterly Reports 99 Nov 10, 2025
4 Insider transactions 2 Nov 05, 2025
4 Insider transactions 2 Oct 17, 2025
4 Insider transactions 2 Oct 17, 2025
4 Insider transactions 2 Oct 03, 2025
4 Insider transactions 1 Oct 03, 2025
4 Insider transactions 2 Oct 03, 2025
4 Insider transactions 2 Oct 03, 2025
8-k 8K-related 14 Oct 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy